<DOC>
	<DOCNO>NCT02836184</DOCNO>
	<brief_summary>With calcium carbonate positive control drug , observe effectiveness safety nicotinic acid hemodialysis patient hyperphosphatemia</brief_summary>
	<brief_title>Nicotinic Acid Hemodialysis Patients With Hyperphosphatemia</brief_title>
	<detailed_description>Hyperphosphatemia important risk factor affect long-term survival patient hemodialysis . Nicotinic acid , well metabolites nicotinamide , find inhibit sodium-phosphorus co-transporter animal intestine . Several study country demonstrate nicotinamide reduce blood phosphorus level end-stage kidney disease patient . The purpose study investigate effectiveness safety nicotinic acid hyperphosphatemia hemodialysis patient ethnic Han live China . The study prospective , randomize , double-blind , placebo-controlled crossover study . Eligible patient randomize 6 wk nicotinic acid calcium carbonate . After 2-wk washout period , patient switch 6 wk alternative therapy . The primary measurement change serum phosphorus whole term arm . Statistical analysis perform use two-sample paired-group test.The significance level analysis set 0.05 . All adverse reaction analyse report , .</detailed_description>
	<mesh_term>Hyperphosphatemia</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Calcium Carbonate</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<criteria>ethnic Han live China , Endstage renal disease（ESRD）patients treat hemodialysis ≥ 3 month , 18 80 year age , serum phosphorus &gt; 1.78 mmol/L , capable give informed consent Be allergic nicotinic acid , dysphagia , pregnant , current medication regimen include niacin niacinamide active liver disease , peptic ulcer disease , full resection parathyroid , malignancy , quit hemodialysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Hemodialysis , Hyperphosphatemia , Nicotinic Acids</keyword>
</DOC>